Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis.
Federico M, Caballero Barrigón MD, Marcheselli L, Tarantino V, Manni M, Sarkozy C, Alonso-Álvarez S, Wondergem M, Cartron G, Lopez-Guillermo A, Issa D, Morschhauser F, Alcoceba M, Kimby E, Rusconi C, Chamuleau M, Holte H, Lockmer S, Montoto S, Gomes da Silva M, Aurer I, Zucca E, Paszkiewicz-Kozik E, Minoia C, Skrypets T, Blaker YN, Salles G, Coiffier B; Aristotle Consortium. Federico M, et al. Among authors: issa d. Lancet Haematol. 2018 Aug;5(8):e359-e367. doi: 10.1016/S2352-3026(18)30090-5. Epub 2018 Jul 4. Lancet Haematol. 2018. PMID: 30078408
Treatment and relative survival in very elderly patients with DLBCL in The Netherlands: a population-based study, 1989 to 2015.
Dinmohamed AG, Issa DE, van der Poel MWM, Schouten HC, Lugtenburg PJ, Chamuleau MED, Zweegman S, Visser O. Dinmohamed AG, et al. Among authors: issa de. Blood Adv. 2017 Sep 22;1(21):1839-1841. doi: 10.1182/bloodadvances.2017011031. eCollection 2017 Sep 26. Blood Adv. 2017. PMID: 29297513 Free PMC article. No abstract available.
Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989-2018.
Durmaz M, Visser O, Posthuma EFM, Brouwer RE, Issa DE, de Jong D, Lam KH, Blijlevens NMA, Zijlstra JM, Chamuleau MED, Lugtenburg PJ, Kersten MJ, Dinmohamed AG. Durmaz M, et al. Among authors: issa de. Blood Cancer J. 2022 Mar 9;12(3):38. doi: 10.1038/s41408-022-00637-1. Blood Cancer J. 2022. PMID: 35264598 Free PMC article.
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands.
Pennings ERA, Durmaz M, Visser O, Posthuma EFM, Issa DE, Chamuleau MED, Lugtenburg PJ, Kersten MJ, Dinmohamed AG. Pennings ERA, et al. Among authors: issa de. Blood Cancer J. 2024 Jan 4;14(1):3. doi: 10.1038/s41408-023-00970-z. Blood Cancer J. 2024. PMID: 38177115 Free PMC article. No abstract available.
Healthcare utilisation in patients with breast cancer or non-Hodgkin lymphoma who experienced febrile neutropenia in the Netherlands: a retrospective matched control study using the PHARMO database.
Issa DE, Gelderblom H, Lugtenburg PJ, van Herk-Sukel MP, Houweling LM, De La Orden M, van der Werf-Langenberg ME, Nortier JW, de Jong FA. Issa DE, et al. Eur J Cancer Care (Engl). 2015 Mar;24(2):232-41. doi: 10.1111/ecc.12189. Epub 2014 Feb 14. Eur J Cancer Care (Engl). 2015. PMID: 24528512
86 results